Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Anastrozole|DRUG: Anastrozole plus tegafur-uracil
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborators: Department of breast and endocrine surgery graduate school of Medicine Osaka University